3SBio spin-off Mandi banks on hair-loss and weight-loss drugs in Hong Kong IPO bid

As 3SBio lines up a Hong Kong spin-off for its hair-loss unit Mandi, the subsidiary is preparing a drug pipeline aimed at acne and obesity.